XML 28 R15.htm IDEA: XBRL DOCUMENT v3.21.2
OTHER ASSETS
 9 Months Ended
Sep. 30, 2021
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]  
OTHER ASSETS

NOTE 9 – OTHER ASSETS

 

On April 9, 2020, pursuant to a licensing agreement entered into in March 2020, the Company received 10-year warrants to purchase 127,000 shares of Sanuwave Health, Inc. at a price of $0.19 per share. The fair value for warrants received is estimated at the date of grant using a Black-Scholes-Merton pricing model with the following underlying assumptions:

 

Price at valuation  $0.12 
Exercise price  $0.19 
Risk free interest   1.52%
Expected term (in years)   9 
Volatility   118.0%

 

The Company considers this to be level 3 inputs and is valued at each reporting period. The fair value of these warrants decreased by $10 during the nine months ended September 30, 2021, leaving a balance of $14.